Aviva PLC Guardant Health, Inc. Transaction History

Aviva PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$109.77 - $165.68 $971,244 - $1.47 Million	-8,848 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$127.04 - $179.1 $361,936 - $510,255	-2,849 Reduced 24.36%	8,848 $1.35 Million
Q4 2020 Feb 10, 2021	SELL	$99.96 - $135.93 $948,020 - $1.29 Million	-9,484 Reduced 44.78%	11,697 $1.51 Million
Q3 2020 Nov 12, 2020	SELL	$80.32 - $111.8 $591,717 - $823,630	-7,367 Reduced 25.81%	21,181 $2.37 Million
Q2 2020 Aug 13, 2020	SELL	$60.49 - $97.5 $1.46 Million - $2.36 Million	-24,214 Reduced 45.89%	28,548 $2.32 Million
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $3.12 Million - $4.69 Million	52,762 New	52,762 $3.67 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.